Oramed, Ltd.

Quick facts

Phase 2 pipeline

• Cohort A: ORMD-0801 · Diabetes
  ORMD-0801 is an oral insulin capsule that mimics the natural insulin production process.
• Cohort B: ORMD-0801
• ORMD-0801 Capsules
• ORMD-0801 Dose # 1
• ORMD-0801 Dose # 2
• ORMD-0801 Treatment A
• ORMD-0801 Treatment B

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Oramed, Ltd. portfolio CI brief
• Oramed, Ltd. pipeline updates RSS